Literature DB >> 10438703

A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.

X Deng1, H Ueda, S B Su, W Gong, N M Dunlop, J L Gao, P M Murphy, J M Wang.   

Abstract

Because envelope gp120 of various strains of human immunodeficiency virus type 1 (HIV-1) downregulates the expression and function of a variety of chemoattractant receptors through a process of heterologous desensitization, we investigated whether epitopes derived from gp120 could mimic the effect. A synthetic peptide domain, designated F peptide, corresponding to amino acid residues 414-434 in the V4-C4 region of gp120 of the HIV-1 Bru strain, potently reduced monocyte binding and chemotaxis response to macrophage inflammatory protein 1beta (MIP-1beta) and stromal cell-derived factor 1alpha (SDF-1alpha), chemokines that use the receptors CCR5 and CXCR4, respectively. Further study showed that F peptide by itself is an inducer of chemotaxis and calcium mobilization in human monocytes and neutrophils. In cross-desensitization experiments, among the numerous chemoattractants tested, only the bacterial chemotactic peptide fMLF, when used at high concentrations, partially attenuated calcium mobilization induced by F peptide in phagocytes, suggesting that this peptide domain might share a 7-transmembrane, G-protein-coupled receptor with fMLF. By using cells transfected with cDNAs encoding receptors that interact with fMLF, we found that F peptide uses an fMLF receptor variant, FPRL1, as a functional receptor. The activation of monocytes by F peptide resulted in downregulation of the cell surface expression of CCR5 and CXCR4 in a protein kinase C-dependent manner. These results demonstrate that activation of FPRL1 on human moncytes by a peptide domain derived from HIV-1 gp120 could lead to desensitization of cell response to other chemoattractants. This may explain, at least in part, the initial activation of innate immune responses in HIV-1-infected patients followed by immune suppression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438703

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.

Authors:  Yoshitaka Sogawa; Takao Ohyama; Hiroaki Maeda; Kazuki Hirahara
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

2.  A bactericidal cecropin-A peptide with a stabilized alpha-helical structure possess an increased killing capacity but no proinflammatory activity.

Authors:  Huamei Fu; Ase Björstad; Claes Dahlgren; Johan Bylund
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

3.  Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients.

Authors:  Samuele E Burastero; Clara Paolucci; Daniela Breda; Armando Soldarini; Fernanda Dorigatti; Elisa Soprana; Hamid Hasson; Priscilla Biswas; Adriano Lazzarin; Antonella Castagna
Journal:  J Clin Immunol       Date:  2006-04-07       Impact factor: 8.317

Review 4.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

5.  HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.

Authors:  Georgette D Kanmogne; Kathy Schall; Jessica Leibhart; Bryan Knipe; Howard E Gendelman; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-10       Impact factor: 6.200

6.  A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis.

Authors:  J Bylund; T Christophe; T Cristophe; F Boulay; A Romero; K Hellstrand; C Dahlgren
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  CXCR4 Tropic HIV-1 gp120 Inhibition of SDF-1α-Induced Chemotaxis Requires Lck and is Associated with Cofilin Phosphorylation.

Authors:  Sergey A Trushin; Gary D Bren; Andrew D Badley
Journal:  Open Virol J       Date:  2010-06-23

Review 8.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

9.  The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.

Authors:  Huamei Fu; Johan Bylund; Anna Karlsson; Sara Pellmé; Claes Dahlgren
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Bi-directional heterologous desensitization between the major HIV-1 co-receptor CXCR4 and the kappa-opioid receptor.

Authors:  Matthew J Finley; Xiaohong Chen; Guiseppe Bardi; Penny Davey; Ellen B Geller; Lily Zhang; Martin W Adler; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2008-06-03       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.